But we're not short of funds after the CR which has just happened. Teva fully funding the CHF trials under an agreement which won Biotech Licensing Deal of the Year. Usually milestone payments are triggered by critical delivery points and when this occurs depends on how the testing is going. There is a halfway mark for both Stage 3 clinical trials where the FDA will conduct a review for possible fast tracked approval based on overwhelming efficacy. I have to stop reading the trading posts... it's going to send me spare. Read the AGM presos for starters. Please.
But we're not short of funds after the CR which has just...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 274918 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 974 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |